Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Why economic indicators matter to investors: indicators help assess health, predict trends, and guide decisions, improving timing and risk management.
27,651 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
A thoughtfully curated slate of 10 weekend reads designed to sharpen your investing instincts. Practical, real-world ...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A major move in the short-term Treasury market reveals how a focused investment strategy can lift cash management ret...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
When a metropolitan bank director sells shares, it catches the eye of investors. This article explains insider filing...
Could MaxLinear be the next stock to 10x? This guide breaks down the company, its AI hardware niche, and the realisti...
A new Fed chair can ripple through markets, but panic isn’t the right play. This article breaks down why chairman kev...
An executive at Fresh Del Monte sold 2,622 shares. This article explains what that means for investors, how to read i...